Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 mRNA Vaccination in High-Risk Populations in the United States
Abstract Introduction In the post-pandemic era, people with underlying medical conditions continue to be at increased risk for severe COVID-19 disease, yet COVID-19 vaccination uptake remains low. This study estimated the clinical and economic impact of updated 2023/24 Moderna COVID-19 vaccination a...
Saved in:
| Main Authors: | Keya Joshi, Mariia Dronova, Ewelina Paterak, Van H. Nguyen, Hagit Kopel, James Mansi, Nicolas Van de Velde, Ekkehard Beck |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-04-01
|
| Series: | Infectious Diseases and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40121-025-01128-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stenotrophomonas Maltophilia Pneumonia in a COPD Patient with Left Atrial Myxoma: A Case of Rare Clinical Presentation
by: Ronak Prakashkumar Shah, et al.
Published: (2025-05-01) -
Diagnostically significant changes in subsets CD11b<sup>+</sup>CD64<sup>-</sup>CD32<sup>+</sup>CD16<sup>+</sup>, CD11b<sup>+</sup>CD64<sup>+</sup>CD32<sup>+</sup>CD16<sup>+</sup> neutrophilic granulocytes of immunocompromised women with chronic infectious and inflammatory diseases of the genital tract of various etiologies
by: S. V. Kovaleva, et al.
Published: (2023-06-01) -
Evaluating the Impact of Age and Comorbidities on COVID-19 Outcomes and Healthcare Costs: A Comparative Analysis of Immunocompromised and General Populations in the United States (EON-US)
by: Corey Fang, et al.
Published: (2025-06-01) -
Chronic and reactivated dengue infection in an immunocompromised host: insights from a case report
by: Ludovic Di Ascia, et al.
Published: (2025-08-01) -
Salmonella pneumonia and empyema in a patient with end-stage liver disease
by: Brittany Davis, et al.
Published: (2024-01-01)